ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.157,68
0,46%
S&P 500
5.473,23
0,77%
Dow Jones
38.778,10
0,49%
Euro vs US Dollar
1,07194
-0,20%
Bitcoin
65.443,70
-1,57%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Nuo Therapeutics Inc (QB) (AURX)

  7. Nuo Therapeutics Inc (QB) (AURX) News

AURX

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:AURX
DatumZeitQuelleÜberschriftSymbolFirma
11/06/202422h26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
22/05/202418h40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202421h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202421h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202414h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
14/02/202419h58Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:AURXNuo Therapeutics Inc (QB)
12/02/202423h33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
22/12/202316h01Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
20/12/202320h18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
20/12/202320h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
20/12/202320h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
20/12/202315h02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
20/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202315h37Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AURXNuo Therapeutics Inc (QB)
08/08/202320h15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
03/08/202322h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
03/08/202322h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
03/08/202322h15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202323h10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/202312h08Edgar (US Regulatory)Annual Report (10-k)USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202200h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AURXNuo Therapeutics Inc (QB)
04/11/202222h28Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202214h36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202214h34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AURXNuo Therapeutics Inc (QB)
30/08/202214h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AURXNuo Therapeutics Inc (QB)
10/08/202219h29Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AURXNuo Therapeutics Inc (QB)
08/08/202222h49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202214h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202214h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:AURX

Kürzlich von Ihnen besucht

DBI
SDXP
SDAX
NASDAQ
AAPL
Apple
CCOM
US500
US 500
NASDAQ
TSLA
Tesla
TG
MBG
MercedesBenz
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MRK
Merck
COIN
SOLUSD
Solana
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
TG
CBK
Commerzbank
CCOM
US30
US 30
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten